Table 1 Risk of death in LPL/WM patients... | American Society of Hematology

Table 1

Risk of death in LPL/WM patients in relation to family history of LPs

	No. of patients	HR*	95% CI
Family history of
Any LP	93	1.34	1.03-1.75
Per increasing number of relatives†		1.22	0.99-1.50
Multiple myeloma	13	1.47	0.76-2.85
Non-Hodgkin lymphoma‡	44	1.43	1.00-2.06
Hodgkin lymphoma	4	0.51	0.13-2.03
Chronic lymphocytic leukemia	17	1.43	0.71-2.88
LPL/WM	16	1.28	0.69-2.39
Monoclonal gammopathy of undetermined significance	11	1.12	0.53-2.37
Any LP (age scale)		1.32	1.02-172
Any LP (year-of-diagnosis scale)		1.31	1.01-1.71
Age at diagnosis (per 1-year increase)		1.06	1.05-1.07
Female gender		0.72	0.65-0.79
Year of diagnosis (per 1-year increase)		0.99	0.98-1.00

	No. of patients	HR*	95% CI
Family history of
Any LP	93	1.34	1.03-1.75
Per increasing number of relatives†		1.22	0.99-1.50
Multiple myeloma	13	1.47	0.76-2.85
Non-Hodgkin lymphoma‡	44	1.43	1.00-2.06
Hodgkin lymphoma	4	0.51	0.13-2.03
Chronic lymphocytic leukemia	17	1.43	0.71-2.88
LPL/WM	16	1.28	0.69-2.39
Monoclonal gammopathy of undetermined significance	11	1.12	0.53-2.37
Any LP (age scale)		1.32	1.02-172
Any LP (year-of-diagnosis scale)		1.31	1.01-1.71
Age at diagnosis (per 1-year increase)		1.06	1.05-1.07
Female gender		0.72	0.65-0.79
Year of diagnosis (per 1-year increase)		0.99	0.98-1.00

Cox model adjusted for age at diagnosis, gender, and year of diagnosis.

The additive risk of each first-degree family member diagnosed with an LP.

Family members with non-Hodgkin lymphoma, excluding those with LPL/WM.